Oct 26 (Reuters) - Sopharma Ad 3JR.BB
* Achieve Life Sciences - co entered into exclusive supply agreement with Sopharma AD for manufacture of Cytisine API and finished tablets
* Achieve Life Sciences Inc - exclusive license agreement provides supply of Cytisine to co for up to 20 years
* Achieve Life Sciences Inc - sopharma agrees to produce CGMP-grade Cytisine for achieve's use in development and commercialization of Cytisine